# Rosalind Advisors, Inc. 13F holdings Q2 2026: $269 million

Rosalind Advisors, Inc. reported $269 million in 13F securities across 35 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Delcath Sys Inc at $41.6 million, 15.4% of the reported value. Since Q1 2026 it opened 9 new positions and exited 12.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $269,201,776
- Positions: 35
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1622627
- Form 13F file number: 028-23857
- Business address: 15 Wellesley Street West Suite 326, Toronto, M4Y 0G7 Ontario, Canada
- SEC filing: [0001622627-26-000022](https://www.sec.gov/Archives/edgar/data/1622627/000162262726000022/0001622627-26-000022-index.htm)

## Top 25 holdings by value

The largest of 35 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Delcath Sys Inc](https://specstream.ai/data/institutional-holders/delcath-sys-inc-24661p807) | COM NEW | 3,300,389 | $41.6 million | No change |
| [Fennec Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/fennec-pharmaceuticals-inc-31447p100) | COM | 3,188,001 | $34.3 million | +279,800 |
| [Xeris Biopharma Holdings Inc](https://specstream.ai/data/institutional-holders/xeris-biopharma-holdings-inc-98422e103) | COM | 2,908,981 | $23 million | -322,719 |
| [Savara Inc](https://specstream.ai/data/institutional-holders/savara-inc-805111101) | COM | 3,178,121 | $19.6 million | -25,600 |
| [Verastem Inc](https://specstream.ai/data/institutional-holders/verastem-inc-92337c203) | COM NEW | 3,986,509 | $15.2 million | +1,848,034 |
| [X4 Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/x4-pharmaceuticals-inc-98420x202) | COM NEW | 3,214,766 | $15 million | No change |
| [Eyepoint Inc](https://specstream.ai/data/institutional-holders/eyepoint-inc-30233g209) | COM NEW | 988,230 | $14.1 million | -48,507 |
| [Cybin Inc](https://specstream.ai/data/institutional-holders/cybin-inc-23256x407) | COM NEW | 1,956,814 | $12.9 million | +425,000 |
| [Vor Biopharma Inc](https://specstream.ai/data/institutional-holders/vor-biopharma-inc-929033207) | COM NEW | 648,600 | $11.9 million | -51,400 |
| [Vaxcyte Inc](https://specstream.ai/data/institutional-holders/vaxcyte-inc-92243g108) | COM | 200,000 | $11.6 million | -90,000 |
| [Mediwound LTD](https://specstream.ai/data/institutional-holders/mediwound-ltd-m68830112) | SHS NEW | 749,054 | $11 million | No change |
| [Celldex Therapeutics Inc New](https://specstream.ai/data/institutional-holders/celldex-therapeutics-inc-new-15117b202) | COM NEW | 200,000 | $7.4 million | -130,000 |
| [Biocryst Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/biocryst-pharmaceuticals-inc-09058v103) | COM | 721,504 | $7.2 million | -201,553 |
| [Profound Med Corp](https://specstream.ai/data/institutional-holders/profound-med-corp-74319b502) | COM NEW | 828,118 | $5.5 million | No change |
| [Talphera Inc](https://specstream.ai/data/institutional-holders/talphera-inc-00444t209) | COM NEW | 5,169,501 | $5.3 million | +1,815,585 |
| [Atea Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/atea-pharmaceuticals-inc-04683r106) | COM | 1,070,550 | $5 million | -101,305 |
| [Myomo Inc](https://specstream.ai/data/institutional-holders/myomo-inc-62857j201) | COM NEW | 3,637,886 | $3.8 million | -209,386 |
| [Ovid Therapeutics Inc](https://specstream.ai/data/institutional-holders/ovid-therapeutics-inc-690469101) | COM | 1,107,994 | $3 million | No change |
| [Neuraxis Inc](https://specstream.ai/data/institutional-holders/neuraxis-inc-64134x201) | COM | 508,055 | $3 million | +221,917 |
| [Abivax SA](https://specstream.ai/data/institutional-holders/abivax-sa-00370m103) | SPONSORED ADS | 20,869 | $2.8 million | New |
| [Inspiremd Inc](https://specstream.ai/data/institutional-holders/inspiremd-inc-45779a846) | COM | 3,905,743 | $2.7 million | No change |
| Regentis Biomaterials LTD | ORDINARY SHARES | 701,685 | $2.5 million | +450,175 |
| Sellas Life Sciences Group I | PUT (put) | 568,700 | $2.3 million | New |
| [Polypid LTD](https://specstream.ai/data/institutional-holders/polypid-ltd-m8001q126) | COM | 389,455 | $2 million | -208,471 |
| Biofrontera Inc | COM NEW | 1,275,609 | $1.2 million | +111,647 |

## New positions in Q2 2026

9 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Abivax SA](https://specstream.ai/data/institutional-holders/abivax-sa-00370m103) | SPONSORED ADS | 20,869 | $2.8 million |
| Sellas Life Sciences Group I | PUT (put) | 568,700 | $2.3 million |
| [Spruce Biosciences Inc](https://specstream.ai/data/institutional-holders/spruce-biosciences-inc-85209e208) | COM NEW | 20,000 | $1.1 million |
| [Pepgen Inc](https://specstream.ai/data/institutional-holders/pepgen-inc-713317105) | COM | 350,000 | $630,000 |
| CG Oncology Inc | CALL (call) | 31,000 | $375,100 |
| Eyepoint Inc | CALL (call) | 50,300 | $130,780 |
| Ishares TR | PUT (put) | 500,000 | $110,000 |
| SPDR Series Trust | PUT (put) | 140,600 | $35,150 |
| Tenax Therapeutics Inc | PUT (put) | 6,200 | $13,950 |

## Positions exited in Q2 2026

12 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [CG Oncology Inc](https://specstream.ai/data/institutional-holders/cg-oncology-inc-156944100) | COM | 100,000 | $6.8 million |
| [Viridian Therapeutics Inc](https://specstream.ai/data/institutional-holders/viridian-therapeutics-inc-92790c104) | COM | 250,401 | $4.9 million |
| Replimune Group Inc | CALL (call) | 1,275,600 | $2.7 million |
| [Definium Therapeutics Inc](https://specstream.ai/data/institutional-holders/definium-therapeutics-inc-24477v105) | COM SHS | 125,000 | $2.4 million |
| [Lipocine Inc New](https://specstream.ai/data/institutional-holders/lipocine-inc-new-53630x203) | COM NEW | 221,616 | $1.8 million |
| [Avalo Therapeutics Inc](https://specstream.ai/data/institutional-holders/avalo-therapeutics-inc-05338f306) | COM NEW | 75,000 | $1.1 million |
| [Annexon Inc](https://specstream.ai/data/institutional-holders/annexon-inc-03589w102) | COM | 200,000 | $1.1 million |
| Invesco QQQ TR | PUT (put) | 250,000 | $1.1 million |
| State STR SPDR S&P 500 ETF T | PUT (put) | 125,000 | $958,500 |
| Viridian Therapeutics Inc | PUT (put) | 263,600 | $52,720 |
| Uniqure NV | CALL (call) | 295,800 | $0 |
| Arrivent Biopharma Inc | CALL (call) | 108,900 | $0 |

## Also on SpecStream

- [Rosalind Advisors, Inc. Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1622627/000162262726000022/0001622627-26-000022-index.htm)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Dental clinics in the United States](https://specstream.ai/data/businesses/dental-clinics/united-states)
- [Public health clinics in the United States](https://specstream.ai/data/businesses/public-health-clinics/united-states)
- [Court reporters in the United States](https://specstream.ai/data/businesses/court-reporters/united-states)
- [Private schools in the United States](https://specstream.ai/data/businesses/private-schools/united-states)
- [Concierge medicine practices in the United States](https://specstream.ai/data/businesses/concierge-medicine-practices/united-states)
- [Pool and hot tub services in the United States](https://specstream.ai/data/businesses/pool-and-hot-tub-services/united-states)
